The National Institutes of Health
Biotechnology Research
Bethesda, MD 956,755 followers
About us
NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement
- Website
-
http://www.nih.gov
External link for The National Institutes of Health
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Bethesda, MD
- Type
- Government Agency
- Specialties
- Intramural Medical Research, Extramural Medical Research, Federal Grant Funding, Scholarship Funding, Medical Research Training, and Biomedical Training at all academic levels
Locations
-
Primary
Get directions
9000 Rockville Pike
Bethesda, MD 20892, US
-
Get directions
P.O. Box 12233
Research Triangle Park, NC 27709, US
-
Get directions
903 South 4th Street
Hamiliton, MT 59840, US
Employees at The National Institutes of Health
Updates
-
🚨BIG News: Today U.S. Department of Health and Human Services (HHS) doubled the budget for NIH’s Childhood Cancer Data Initiative, a surge designed to accelerate the development of improved diagnostics, treatments, and prevention strategies. The increase in funding comes as President Trump signed an Executive Order on unlocking cures for pediatric cancer using AI. Read more ➡️ https://bit.ly/3KmsMef
-
-
Dr. Anthony Letai was sworn in today as the new director of NIH’s National Cancer Institute. Dr. Letai holds decades of experience studying cell death in cancer, identifying predictive biomarkers, and developing new treatments, including cellular immunotherapies. Dr. Letai will oversee the nation’s premier cancer research agency which works to dramatically reduce the prevalence of cancer, a critical step in our quest to reduce chronic illness and Make America Healthy Again. Welcome, Dr. Letai! Read more ➡️ https://bit.ly/48pOZSH
-
-
HHS is seeking nominations of individuals to serve as non-federal public members on the Interagency Autism Coordinating Committee (IACC). The IACC coordinates Federal efforts and provides advice to the Secretary of Health and Human Services on issues related to autism spectrum disorder (ASD). For more information on the IACC Call for Nominations, visit this page: https://lnkd.in/e6fwGq8e.
-
-
Substance use disorders are chronic, treatable conditions from which people can recover. During Recovery Month, learn about effective treatments for substance use disorders and how NIH supports and conducts research to develop new and improved treatments to help people on the path to recovery: https://bit.ly/4pmV0Wd
-
NIH's National Cancer Institute (NCI) released its Professional Judgement Budget Proposal for FY27. It describes the resources needed to ensure that the cancer research enterprise stays strong, delivers on the opportunities before us, and changes what it means to have cancer. Read more ➡️ https://go.nih.gov/omQoeBY
-
-
Blood infections of Staphylococcus aureus, or “staph,” can be deadly. Standard treatment often lasts for weeks and can limit daily activities. An NIH-supported study showed that the long-acting drug dalbavancin can be delivered in just two doses and be just as effective as traditional, more burdensome treatments for complicated staph infections. https://bit.ly/46j7RRH
-
An NIH research team identified proteins in the blood that can accurately detect amyotrophic lateral sclerosis (ALS) long before symptoms emerge. The discovery may offer the first definitive ALS diagnostic test and a promising way to track disease progression in clinical trials. https://bit.ly/4mtVeYE
-
BREAKING NEWS❗ Today, NIH announced the award of contracts for launching the Standardized Organoid Modeling (SOM) Center, a national resource that will be dedicated to using cutting-edge technologies to develop standardized organoid-based new approach methodologies (NAMS) that deliver robust, reproducible, and patient-centered research findings to reduce reliance on animal modeling. With contracts totaling $87 million for the first three years, the center will be housed at the Frederick National Laboratory for Cancer Research (FNLCR), a research facility supported by NIH’s National Cancer Institute (NCI). Read more: https://bit.ly/4pBYT9T
-
-
Just launched! NIH invites you to learn more about the NOURISH Autoimmunity Challenge, a new competition offering participants the chance to win $10,000 for innovative ideas integrating diet and nutrition into autoimmune disease research. Join us on September 30th, 2025, for an informational webinar to understand: ● How the challenge works ● Who is eligible to apply ● What reviewers will be looking for in submissions ● Key dates and deadlines 📅 Date: Tuesday, September 30, 2025 🕜 Time: 1:30 – 2:30 PM ET This competition is open to individuals, caregivers, advocacy groups, health professionals, and researchers. Bring your ideas forward and help transform the future of autoimmune disease research. 👉 Register for the webinar: https://lnkd.in/epwM6dpc #NOURISHChallenge #NutritionResearch #Autoimmunity #NIH
-